Antiviral activity of natural compounds and their derivatives;Aktywność przeciwwirusowa substancji pochodzenia naturalnego oraz ich pochodnych

Postepy Mikrobiologii

Volumn 44, Issue 3, 2005, Pages 239-252

  Krawczyk, Ewa ^a   Łuczak, Mirosław ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

AMENTOFLAVONE; ANTHRAQUINONE; ANTIVIRUS AGENT; APHIDICOLIN; ARTEMISIN; CHRYSOSPLENOL C; DITERPENE; EUDESMANE DERIVATIVE; FLAVONOID; GALACTAN; GLYCOSIDE; GLYCYRRHIZIC ACID; HESPERETIN; HESPERIDIN; IRIDOID; LIGNAN; NATURAL PRODUCT; POLYSACCHARIDE; QUERCETIN; QUERCETIN 3 METHYL ETHER; RESVERATROL; SESQUITERPENE; SESQUITERPENE DERIVATIVE; TERPENE; TRITERPENE DERIVATIVE; UNCLASSIFIED DRUG;

ANTIVIRAL ACTIVITY; ARTICLE; BIOLOGICAL ACTIVITY; DNA VIRUS; NONHUMAN; RNA VIRUS; VIRUS INFECTION;

DNA VIRUSES; FUNGI; RNA VIRUSES;

EID: 27944445315     PISSN: 00794252     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (100)

1. Alche L.E., Ferek G.A., Meo M., Coto C.E., Maier M.S.: An antiviral meliacarpin from leaves of Melia azedarach L. Z. Naturforsch. [C], 58, 215-219 (2003)
2. Amoros M., Simoes C.M.O., Girre L., Sauvager F., Cormier M.: Synergistic effect of flavones and flavonols against herpes simplex virus type 1 in cell culture. Comparison with the antiviral of propolis. J. Nat. Prod. 55, 1732-1740 (1992)
3. Armaka M., Papanikolaou E., Sivropoulou A., Arsenakis M.: Antiviral properties of isoborneol, a potent inhibitor of herpes simplex virus type 1. Antiviral Res. 43, 79-92 (1999)
4. Berge J.P., Bourgougnon N., Alban S., Pojer F., Billaudel S., Chermann J.C., Robert J.M., Franz G.: Antiviral and anticoagulant activities of a water-soluble fraction of the marine diatom Haslea ostrearia. Planta Med. 65, 604-609 (1999)
5. Bermejo P., Abad M.J., Diaz A.M., Fernandez L., Santos J.D., Sanchez S., Villaescusa L., Carrasco L., Irurzun A.: Antiviral activity of seven iridoids, three saikosaponins and one phenylpropanoid glycoside extracted from Bupleurum rigidum and Scrophularia scorodonia. Planta Med. 68, 106-110 (2002)
6. Carlucci M.J., Scolaro L.A., Errea M.I., Matulewicz M.C., Damonte E.B.: Antiviral activity of natural sulphated galactans on herpes virus multiplication in cell culture. Planta Med. 63, 429-432 (1997)
7. Centers for Disease Control and Prevention (CDC).: West Nile virus activity-United States, November 6-12, 2003. M.M.W.R. Morb. Mortal. Wkly. Rep. 14, 1105-1106 (2003)
8. Chantrill B.H., Coulthard C.E., Dickinson L., Inkley G.W., Morris W., Pyle A.H.: The action of plant extracts on a bacteriophage of Pseudomonas pyocyanea and on influenza A virus. J. Gen. Microbiol. 6, 74-84 (1952)
9. Chen H.C., Chou C.K., Lee S.D., Wang J.C., Yeh S.F.: Active compounds from Saussurea lappa Clarks that suppress hepatitis B virus surface antigen gene expression in human hepatoma cells. Antiviral Res. 27, 99-109 (1995)
10. Cinatl J., Morgenstern B., Bauer G., Chandra P., Rabenau H., Doerr H.W.: Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus. Lancet, 361, 2045-2046 (2003)
11. Cordell G.A.: Changing strategies in natural products chemistry. Phytochemistry, 40, 1585-1612 (1995)
12. Craigo J., Callahan M., Huang R.C., DeLucia A.L.: Inhibition of human papillomavirus type 16 gene expression by nordihydroguaiaretic acid plant lignan derivatives. Antiviral Res. 47, 19-28 (2000)
13. Czerny B.: Uwagi na temat ubocznych efektów stosowania roślinnych środków leczniczych. Post. Fitoter. 3, 21-23 (2000)
14. Daniewski W.M., Vidari G.: Constituents of Lactarius (Mushrooms) (w:) Progress in the Chemistry of Organic Natural Products, red. Herz W., Falk H., Kirby G.W., Moore R.E., Tamm C., Springer-Verlag Wien New York, 1999, s. 70-171
15. Daniewski W.M., Gumułka M., Przesmycka D., Ptaszyńska K., Błoszyk E., Drożdż B.: Sesquiterpenes of Lactarius origin, antifeedant structure-activity relationships. Phytochemistry, 38, 1161-1168 (1995)
16. De Clercq E.: 2001 ASPET Otto Krayer Award Lecture. Molecular targets for antiviral agents. J. Pharmacol. Exp. Ther. 297, 1-10 (2001)
17. De Clercq E.: Strategies in the design of antiviral drugs. Nat. Rev. Drug. Discov. 1, 13-25 (2002)
18. De Clercq E. : Highlights in the development of new antiviral agents. Mini. Rev. Med. Chem. 2, 163-175 (2002)
19. De Clercq E.: Clinical potential of the acyclic nucleoside phosphonates cidofovir, adefovir, and tenofovir in treatment of DNA virus and retrovirus infections. Clin. Microbiol. Rev. 16, 569-596 (2003)
20. Denyer C.V., Jackson P., Loakes D.M., Ellis M.R., Young D.A.: Isolation of antirhinoviral sesquiterpenes from ginger (Zingiber officinale). J. Nat. Prod. 57, 658-662 (1994)
21. De Tommasi N., Pizza C.: Structure and in vitro antiviral activity of sesquiterpene glycosides from Calendula arvensis. J. Nat. Prod. 53, 830-835 (1990)
22. Docherty J.J., Fu M.M., Stiffler B.S., Limperos R.J., Pokabla C.M., DeLucia A.L.: Resveratrol inhibition of herpes simplex virus replication. Antiviral Res. 43, 145-155 (1999)
23. Duarte M.E., Noseda D.G., Noseda M.D., Tulio S., Pujol C.A., Damonte E.B.: Inhibitory effect of sulfated galactans from the marine alga Bostrychia montagnei on herpes simplex virus replication in vitro. Phytomedicine, 8, 53-58 (2001)
24. Efferth T., Marschall M., Wang X., Huong S.M., Hauber I., Olbrich A., Kronschnabl M., Stamminger T., Huang E.S.: Antiviral activity of artesunate towards wild-type, recombinant, and ganciclovir-resistant human cytomegaloviruses. J. Mol. Med. 80, 233-242 (2002)
25. Fan J., Ma W.H., Qian J., Chen Z., Huang D.S., Wang W.L., Zheng S.S.: Cytomegalovirus infection in liver transplant recipients. Hepatobiliary Pancreat. Dis. Int. 1, 30-32 (2002)
26. Flekhter O.B., Boreko E.I., Nigmatullina L.R., Pavlova N.I., Nikolaeva S.N., Savinova O.V., Eremin V.F., Baltina L.A., Galin F.Z., Tolstikov G.A.: Synthesis and antiviral activity of hydrazides and substituted benzalhydrazides of betulinic acid and its derivatives (artykuł w jȩzyku rosyjskim). Bioorg. Khim. 29, 326-332 (2003)
27. Gedara S.R., Abdel-Halim O.B., el-Sharkawy S.H., Salama O.M., Shier T.W., Halim A.F.: New erythroxane-type diterpenoids from Fagonia boveana (Hadidi) Hadidi & Graf. Z. Naturforsch. [C], 58, 23-32 (2003)
28. Glatthaar-Saalmuller B., Sacher F., Esperester A.: Antiviral activity of an extract derived from roots of Eleutherococcus senticosus. Antiviral Res. 50, 223-228 (2001)
29. Hamburger M.: Tracking bioactivity in plant extracts - new concepts and approaches (w:) Society for Medicinal Plant Research 50 Years 1953-2003 A Jubilee Edition, red. Sprecher E., Caesar W., Wissenschaftliche Verlagsgesellschaft mbH, Stuttgart, 2003, s. 109-122
30. Hayashi K., Hayashi T., Ujita K., Takaishi Y.: Characterization of antiviral activity of a sesquiterpene, triptofordin C-2. J. Antimicrob. Chemother. 37, 759-768 (1996)
31. Hirsch S., Rudi A., Kashman T.: New avarone and avarol derivatives from the marine sponge Dysidea cinerea. J. Nat. Prod. 54, 92-97 (1991)
32. Hoang V.D., Tan G.T., Zhang H.J., Tamez P.A., Hung N.V., Cuong N.M., Soejarto D.D., Fong H.H., Pezzuto J.M.: Natural anti-HIV agents-part I: (+)-demethoxyepiexcelsin and verticillatol from Litsea verticillata. Phytochemistry, 59, 325-329 (2002)
33. Hostettmann K., Wolfender J., Marston A.: Hyphenated HPLC techniques for screening and quality control (w:) Society for Medicinal Plant Research 50 Years 1953-2003 A Jubilee Edition, red. Sprecher E., Caesar W., Wissenschaftliche Verlagsgesellschaft mbH, Stuttgart, 2003, s. 99-108
34. Jambor J., Czosnowska E.: Preparaty ze świeżych roślin. Post. Fitoter. 8 (1-2), 2-5 (2002)
35. Jassim S.A., Naji M.A.: Novel antiviral agents: a medicinal plant perspective. J. Appl. Microbiol. 95, 412-427 (2003)
36. Jiang R.W., Ma S.C., But P.P., Mak T.C.: New antiviral cassane furanoditerpenes from Caesalpinia minax. J. Nat. Prod. 64, 1266-1272 (2001)
37. Kanokmedhakul S., Kanokmedhakul K., Prajuabsuk T., Soytong K., Kongsaeree P., Suksamrarn A.: A bioactive triterpenoid and vulpinic acid derivatives from the mushroom Scleroderma citrinum. Planta Med. 69, 568-571 (2003)
38. Kaul T.N., Middleton Jr E., Ogra P.L.: Antiviral effect of flavonoids on human viruses. J. Med. Virol. 15, 71-79 (1985)
39. Kȩdzia B., Alkiewicz J., Han S.: Znaczenie olejku z drzewa herbacianego w fitoterapii. Cz. I. Skład olejku i jego własciwości biologiczne. Post. Fitoter. 2, 36-40 (2000)
40. Kimberlin D.W., Whitley R.J.: Antiviral resistance - an emerging problem. Antiviral Res. 26, 365-368 (1995)
41. Kittakoop P., Wanasith S., Watts P., Kramyu J., Tanticharoen M., Thebtaranonth Y: Potent antiviral potamogetonyde and potamogetonol, new furanoid labdane diterpenes from Potamogeton malaianus. J. Nat. Prod. 64, 385-388 (2001)
42. Kobus M., Przybylski M., Daniewski W., Krawczyk E., Łuczak M.: Właściwości biologiczne seskwiterpenów pochodza̧cych z grzybów z rodzaju Lactarius. Probl. Hig. 71, 134-139 (2001)
43. Kohlmünzer S.: Farmakognozja. Podrȩcznik dla studentów farmacji. PZWL, Warszawa 1985
44. Konowalchuk J., Speirs J.I.: Virus inactivation by grapes and wines. Appl. Environ. Microbiol. 32, 757-763 (1976)
45. Konowalchuk J., Speirs J.I.: Antiviral effect of commercial juices and beverages. Appl. Environ. Microbiol. 35, 1219-1220 (1978)
46. Konowalchuk J., Speirs J.I.: Antiviral effect of apple beverages. Appl. Environ. Microbiol. 36, 798-801 (1978)
47. Kopczacki P., Gumulka M., Masnyk M., Grabarczyk H., Nowak G., Daniewski W.M.: Synthesis and antifeedant properties of N-benzoylphenylisoserinates of Lactarius sesquiterpenoid alcohols. Phytochemistry, 58, 775-787 (2001)
48. Kott V., Barbini L., Cruanes M., Munoz J.D., Vivot E., Cruanes J., Martino V., Ferraro G., Cavallaro L., Campos R.: Antiviral activity in Argentine medicinal plants. J. Ethnopharmacol. 64, 79-84 (1999)
49. Krawczyk E., Łuczak M., Kobus M., Bańka D., Daniewski W.: Antiviral activity of N-benzoylphenylisoserinates of Lactarius sesquiterpenoid alcohols in vitro. Planta Med. 69, 552-554 (2003)
50. Kuo YC., Chen C.C., Tsai W.J., Ho Y.H.: Regulation of herpes simplex virus type 1 replication in Vero cells by Psychotria serpens: relationship to gene expression, DNA replication, and protein synthesis. Antiviral Res. 51, 95-109 (2001)
51. Lin J.C.: Mechanism of action of glycyrrhizic acid in inhibition of Epstein-Barr virus replication in vitro. Antiviral Res. 59, 41-47 (2003)
52. Lin Y.M., Anderson H., Flavin M.T., Pai Y.H., Mata-Greenwood E., Pengsuparp T., Pezzuto J.M., Schinazi R.F., Hughes S.H., Chen F.C.: In vitro anti-HIV activity of biflavonoids isolated from Rhus succedanea and Garcinia multiflora. J. Nat. Prod. 60, 884-888 (1997)
53. Lin Y.M., Flavin M.T., Schure R., Chen F.C., Sidwell R., Barnard D.L., Huffman J.H., Kern E.R.: Antiviral activities of biflavonoids. Planta Med. 65, 120-125 (1999)
54. Locher C.P., Burch M.T., Mower H.F., Berestecky J., Davis H., Van Poel B., Lasure A., Vanden Berghe D.A., Vlietinck A.J.: Anti-microbial activity and anti-complement activity of extracts obtained from selected Hawaiian medicinal plants. J. Ethnopharmacol. 49, 23-32 (1995)
55. Loya S., Hizi A.: The inhibition of human immunodeficiency virus type I reverse transcriptase by avarol and avarone derivatives. FEBS Lett. 269, 131-134 (1990)
56. Lutomski J., Mścisz A.: Znaczenie prewencyjne zwia̧ zków polifenolowych zawartych w winogronach. Post. Fitoter. 10: 6-10 (2003)
57. Ma L.Y., Ma S.C., Wei F., Lin R.C., But P.P., Lee S.H., Lee S.F.: Uncinoside A and B, two new antiviral chromone glycosides from Selaginella uncinata. Chem. Pharm. Bull. (Tokyo). 51, 1264-1267 (2003)
58. Matsuo R., Ball M.A., Kobayashi M., Herndon D.N., Pollard R.B., Suzuki F.: Effects of a traditional Chinese herbal medicine, Kanzo-bushi-to, on the resistance of thermally injured mice infected with herpes simplex virus type 1. Int. J. Immunopharmacol. 16, 855-863 (1994)
59. Mayer A.M., Hamann M.T.: Marine pharmacology in 1999: compounds with antibacterial, anticoagulant, antifungal, anthelmintic, anti-inflammatory, antiplatelet, antiprotozoal and antiviral activities affecting the cardiovascular, endocrine, immune and nervous systems, and other miscellaneous mechanisms of action. Comp. Biochem. Physiol. C Toxicol. Pharmacol. 132, 315-339 (2002)
60. Mazumder S., Ghosal P.K., Pujol C.A., Carlucci M.J., Damonte E.B., Ray B.: Isolation, chemical investigation and antiviral activity of polysaccharides from Gracilaria corticata (Gracilariaceae, Rhodophyta). Int. J. Biol. Macromol. 31, 87-95 (2002)
61. McCutcheon A.R., Roberts T.E., Gibbons E., Ellis S.M., Babiuk L.A., Hancock R.E., Towers G.H.: Antiviral screening of British Columbian medicinal plants. J. Ethnopharmacol. 49, 101-110 (1995)
62. el-Mekkawy S., Meselhy M.R., Kusumoto I.T., Kadota S., Hattori M., Namba T: Inhibitory effects of Egyptian folk medicines on human immunodeficiency virus (HIV) reverse transcriptase. Chem. Pharm. Bull. (Tokyo), 43, 641 -648 (1995)
63. Michaelis M., Langer K., Vogel J.U., Kreuter J., Rabenau H., Doerr H.W., Cinatl J.: In vitro antiviral activity of aphidicolin and its derivates. Synergistic effects of aphidicolin with other antiviral drugs. Arzneimittelforschung, 52, 393-399 (2002)
64. Mitrocotsa D., Mitaku S., Axarlis S., Harvala C., Malamas M.: Evaluation of the antiviral activity of kaempferol and its glycosides against human cytomegalovirus. Planta Med. 66, 377-379 (2000)
65. Mucsi I., Molnar J., Hohmann J., Redei D.: Cytotoxicities and anti-herpes simplex virus activities of diterpenes isolated from Euphorbia species. Planta Med. 67, 672-674 (2001)
66. Nagasaka K., Kurokawa M., Imakita M., Terasawa K., Shiraki K.: Efficacy of Kakkon-to, a traditional herb medicine, in herpes simplex virus type 1 infection in mice. J. Med. Virol. 46, 28-34 (1995)
67. Panasiak W., Wleklik M., Oraczewska A., Luczak M.: influence of flavonoids on combined experimental infections with EMC virus and Staphylococcus aureus in mice. Acta Microbiol. Polon. 38, 185-188 (1989)
68. Panchagnula R.: Pharmaceutical aspects of paclitaxel. Int. J. Pharm. 172, 1-15 (1998)
69. Phillipson J.D.: Phytochemistry and medicinal plants. Phytochemistry, 56, 237-243 (2001)
70. Phillipson J.D.: 50 years of medicinal plant research - every progress in methodology is a progress in science. Planta Med. 69, 491-495 (2003)
71. Pujol C.A., Estevez J.M., Carlucci M.J., Ciancia M., Cerezo A.S., Damonte E.B.: Novel DL-galactan hybrids from the red seaweed Gymnogongrus torulosus are potent inhibitors of herpes simplex virus and dengue virus. Antivir. Chem. Chemother: 13, 83-89 (2002)
72. Sanchez Palomino S., Abad M.J., Bedoya L.M., Garcia J., Gonzales E., Chiriboga X., Bermejo P., Alcami J.: Screening of South American plants against human immunodeficiency virus: preliminary fractionation of aqueous extract from Baccharis trinervis. Biol. Pharm. Bull. 25, 1147-1150 (2002)
73. Schaeffer D.J., Krylov V.S.: Anti-HIV activity of extracts and compounds from algae and cyanobacteria. Ecotoxicol. Environ. Safety, 45, 208-227 (2000)
74. Schroder H.C., Sarin P.S., Rottmann M., Wenger R., Maidhof A., Renneisen K., Muller W.E.: Differential modulation of host cell and HIV gene expression by combinations of avarol and AZT in vitro. Biochem. Pharmacol. 37, 3947-3952 (1988)
75. Semple S.J., Reynolds G.D., O'Leary M.C., Flower R.L.: Screening of Australian medicinal plants for antiviral activity. J. Ethnopharmacol. 60, 163-172 (1998)
76. Semple S.J., Nobbs S.F., Pyke S.M., Reynolds G.D., Flower R.L.: Antiviral flavonoid from Pterocaulon sphacelatum, an Australian Aboriginal medicine. J. Ethnopharmacol. 68, 283-288 (1999)
77. Semple S.J., Pyke S.M., Reynolds G.D., Flower R.L.: In vitro antiviral activity of the anthraquinone chrysophanic acid against poliovirus. Antiviral Res. 49, 169-178 (2001)
78. Serkedjieva J.: Antiinfective activity of a plant preparation from Geranium sanguineum L. Pharmazie, 52, 799-802 (1997)
79. Serkedjieva J.: Antiherpes virus effect of the red marine alga Polysiphonia denudata. Z. Naturforsch. [C], 55, 830-835 (2000)
80. Serkedjieva J., Ivancheva S.: Antiherpes virus activity of extracts from the medicinal plant Geranium sanguineum L. J. Ethnopharmacol. 64, 59-68 (1999)
81. Serkedjieva J., Konaklieva M., Dimitrova-Konaklieva S., Ivanova V., Stefanov K., Popov S.: Antiinfluenza virus effect of extracts from marine algae and invertebrates. Z. Naturforsch. [C], 55, 87-93 (2000)
82. Sia I.G., Patel R.: New strategies for prevention and therapy of eytomegalovirus infection and disease in solid-organ transplant recipients. Clin. Microbiol. Rev. 13, 83-121 (2000)
83. Simoes C.M.O., Falkenberg M., Auler Mentz L., Schenkel E.P., Amoros M.: Antiviral activity of South Brazilian medicinal plant extracts. Phytomedicine, 6, 205-214 (1999)
84. Simon B., Anke T., Anders U., Neuhaus M., Hansske F.: Collybial, a new antibiotic sesquiterpenoid from Collybia confluens (Basidiomycetes). Z. Naturforsch. [C], 50, 173-180 (1995)
85. Singh S.B., Felock P., Hazuda D.J.: Chemical and enzymatic modifications of integric acid and HIV-1 integrase inhibitory activity. Bioorg. Med. Chem. Lett. 10, 235-238 (2000)
86. Sotanaphun U., Lipipun V., Suttisri R., Bavovada R.: A new antiviral and antimicrobial sesquiterpene from Glyptopetalum sclerocarpum. Planta Med. 65, 257-258 (1999)
87. Sydiskis R.J., Owen D.G., Lohr J.L., Rosler K.H., Blomster R.N.: Inactivation of enveloped viruses by anthraquinones extracted from plants. Antimicrob. Agents Chemother. 35, 2463-2466 (1991)
88. Takahashi K., Matsuda M., Ohashi K., Taniguchi K., Nakagomi O., Abe Y., Mori S., Sato N., Okutani K., Shigeta S.: Analysis of anti-rotavirus activity of extract from Stevia rebaudiana. Antiviral Res. 49, 15-24 (2001)
89. Tan R.X., Zheng W.F., Tang H.Q.: Biologically active substances from the genus Artemisia. Planta Med. 64, 295-302 (1998)
90. Taylor R.S., Manandhar N.P., Hudson J.B., Towers G.H.: Antiviral activities of Nepalese medicinal plants. J. Ethnopharmacol. 52, 157-163 (1996)
91. Tyler V.E.: Phytomedicines: Past, Present, and Future - from an American Point of View (w:) Society for Medicinal Plant Research 50 Years 1953-2003 A Jubilee Edition, red. Sprecher E., Caesar W., Wissenschaftliche Verlagsgesellschaft mbH, Stuttgart, 2003, s. 85-92
92. Tziveleka L.A., Vagias C., Roussis V.: Natural products with anti-HIV activity from marine organisms. Curr. Top. Med. Chem. 3, 1512-1535 (2003)
93. UNAIDS.: AIDS epidemic update 2003, Genewa, 2003
94. Vrijsen R., Everaert L., Van Hoof L.M., Vlietinck A.J., Vanden Berghe D.A., Boeye A.: The poliovirus-induced shut-off of cellular protein synthesis persists in the presence of 3-methylquercetin, a flavonoid which blocks viral protein and RNA synthesis. Antiviral Res. 7, 35-42 (1987)
95. WHO Website 21 kwietnia 2004 roku (online).: Summary of probable SARS cases with onset of illness from 1 November 2002 to 31 July 2003, http://www.who.int/csr/sars/country/table2004_04_21 /en/ (12 sierpnia 2004 roku, data ostatniego sprawdzenia).
96. Wleklik M., Łuczak M., Panasiak W., Kobus M., Lammer-Zarawska E.: Structural basis for antiviral activity of flavonoids - naturally occurring compounds. Acta Virol. 32, 522-525 (1988)
97. Wright A.E., Rueth S.A., Cross S.S.: An antiviral sesquiterpene hydroquinone from the marine sponge Strongylophora hartmani. J. Nat. Prod. 54, 1108-1111 (1991)
98. Yamasaki K., Otake T., Mori H., Morimoto M., Ueba N., Kurokawa Y., Shiota K., Yuge T.: Screening test of crude drug extract on anti-HIV activity (artykuł w jȩzyku japońskim). Yakugaku Zasshi. 113, 818-824 (1993)
99. Yip L., Pei S., Hudson J.B., Towers G.H.: Screening of medicinal plants from Yunnan Province in southwest China for antiviral activity. J. Ethnopharmacol. 34, 1-6 (1991)
100. Zgorniak-Nowosielska I., Grzybek J., Manolova N., Serkedjieva J., Zawilinska B.: Antiviral activity of Flos verbasci infusion against influenza and Herpes simplex viruses. Arch. Immunol. Ther. Exp. (Warsz). 39, 103-108 (1991)